Department of Medicine and Surgery, University of Parma, Parma, Italy.
Department of Medicine and Surgery, University of Parma, Parma, Italy.
Int J Infect Dis. 2020 Jul;96:387-389. doi: 10.1016/j.ijid.2020.05.035. Epub 2020 May 14.
SARS-CoV-2 emerged in China in December 2019 and has now been declared a pandemic by the World Health Organization. This paper described the case of a 7-week-old suckling baby from Italy who was SARS-CoV-2-positive only by the cell culture method, with no clinical suspicion of and/or risk factors for SARS-CoV-2 infection. The baby was referred to hospital, with signs and symptoms of upper respiratory tract infection, before the virus had spread to the province. Nasal and pharyngeal swabs and a nasopharyngeal aspirate were used for conventional and molecular diagnostic assays not including the SARS-CoV-2 virus. Bacteria referred to the resident population were revealed in nasal and pharyngeal swabs. No viruses were detected using both immunofluorescence assay and nucleic acid amplification assays in the nasopharyngeal aspirate. The baby was discharged in good condition after 3 days of hospitalisation. Later, a cytopathic effect on the cell monolayers currently used for respiratory viruses was observed and the viral particles were identified as Coronaviridae by transmission electron microscopy. SARS-CoV-2 was identified by RT-PCR performed both on cell culture and on the stored aliquot of the original sample. The virus isolate was named SARS-Cov-2/human/Parma/1/2020. Cell culture still remains the only reference diagnostic method also for emerging viruses, allowing it to reveal cytopathogenic viruses and demonstrate their infectivity.
2019 年 12 月,SARS-CoV-2 在中国出现,世界卫生组织现已宣布其为大流行。本文描述了一例来自意大利的 7 周龄婴儿,仅通过细胞培养方法呈 SARS-CoV-2 阳性,无 SARS-CoV-2 感染的临床疑似症状和/或危险因素。在病毒传播到该省之前,该婴儿因上呼吸道感染的症状和体征而被送往医院。使用常规和分子诊断检测方法,包括但不限于 SARS-CoV-2 病毒检测,对鼻和咽拭子以及鼻咽抽吸物进行了检测。鼻和咽拭子中发现了居民群体中的细菌。鼻咽抽吸物的免疫荧光检测和核酸扩增检测均未检测到病毒。该婴儿在住院 3 天后状况良好出院。后来,在目前用于呼吸道病毒的细胞单层上观察到细胞病变效应,并用透射电子显微镜鉴定这些病毒颗粒为冠状病毒科。通过对细胞培养物和原始样本的储存等分试样进行 RT-PCR,鉴定出 SARS-CoV-2。该病毒分离株被命名为 SARS-CoV-2/人/帕尔马/1/2020。细胞培养仍然是新兴病毒的唯一参考诊断方法,它可以揭示细胞病变病毒并证明其感染性。